SCP Vitalife Partners II LP, 10% Owner at Recro Pharma, Inc. (REPH), sold 134,931 shares at $8.04 ($1.1M) on 2017-03-14, disclosed to the SEC on 2017-03-20.
Open-market sale of $1.1M REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.04 | 16,328 | $131K | 12.2% |
| 2 | $8.04 | 16,328 | $131K | 12.2% |
| 3 | $8.04 | 16,328 | $131K | 12.2% |
| 4 | $8.01 | 19,161 | $153K | 14.2% |
| 5 | $8.01 | 19,161 | $153K | 14.2% |
| 6 | $8.01 | 19,161 |
| $154K |
| 14.2% |
| 7 | $7.93 | 9,488 | $75K | 7.0% |
| 8 | $7.93 | 9,488 | $75K | 7.0% |
| 9 | $7.93 | 9,488 | $75K | 7.0% |
| Total | $8.00 avg | 134,931 | $1.1M | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $42K | — | Filing → |
| REPH | SELL | 2018-01-04 | $689K | — | Filing → |
| REPH | SELL | 2018-01-02 | $338K | — | Filing → |